Terms: = Liver cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Prognosis
661 results:
1. DCAF1 interacts with PARD3 to promote hepatocellular carcinoma progression and metastasis by activating the akt signaling pathway.
Zhang J; Shi Y; Ding K; Yu W; He J; Sun B
J Exp Clin Cancer Res; 2024 May; 43(1):136. PubMed ID: 38711082
[TBL] [Abstract] [Full Text] [Related]
2. YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the akt/β-catenin axis.
Shi X; Hu Z; Bai S; Zong C; Xue H; Li Y; Li F; Chen L; Xuan J; Xia Y; Wei L; Shen F; Wang K
J Gene Med; 2024 May; 26(5):e3689. PubMed ID: 38676365
[TBL] [Abstract] [Full Text] [Related]
3. An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma.
Du Z; Han X; Zhu L; Li L; Castellano L; Stebbing J; Peng L; Wang Z
BMC Med Genomics; 2024 Apr; 17(1):86. PubMed ID: 38627727
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Significance of Iron Metabolism and Immune-Related Genes as Risk Markers in Hepatocellular Carcinoma.
Tang S; Chen H
J Environ Pathol Toxicol Oncol; 2024; 43(3):51-67. PubMed ID: 38608145
[TBL] [Abstract] [Full Text] [Related]
5. Extracellular Vesicles Contribute to Viral-Induced Hepatocellular Carcinoma: Understanding Their Involvement in Viral Hepatitis and Their Potential as Biomarkers for Early Hepatocellular Carcinoma Detection.
Tahir F; Farooq M; Malik MA; Manzoor S
Viral Immunol; 2024 Apr; 37(3):159-166. PubMed ID: 38588555
[TBL] [Abstract] [Full Text] [Related]
6. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/akt1-involved EMT in hepatocellular carcinoma.
Yang Y; Huang L; Zhang N; Deng YN; Cao X; Liang Y; Hou H; Luo Y; Yang Y; Li Q; Liang S
Cell Commun Signal; 2024 Apr; 22(1):206. PubMed ID: 38566133
[TBL] [Abstract] [Full Text] [Related]
7. Indoxyl sulfate contributes to colorectal cancer cell proliferation and increased EGFR expression by activating AhR and akt.
Ichisaka Y; Yano S; Nishimura K; Niwa T; Shimizu H
Biomed Res; 2024; 45(2):57-66. PubMed ID: 38556263
[TBL] [Abstract] [Full Text] [Related]
8. Investigation of prunetrin induced G2/M cell cycle arrest and apoptosis via akt/mTOR/MAPK pathways in hepatocellular carcinoma cells.
Abusaliya A; Bhosale PB; Kim HH; Park MY; Jeong SH; Lee S; Kim GS
Biomed Pharmacother; 2024 May; 174():116483. PubMed ID: 38552440
[TBL] [Abstract] [Full Text] [Related]
9. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract] [Full Text] [Related]
10. Long non-coding RNAFOXD1-AS1 modulated CTCs epithelial-mesenchymal transition and immune escape in hepatocellular carcinoma in vitro by sponging miR-615-3p.
Guo BL; Zheng QX; Jiang YS; Zhan Y; Huang WJ; Chen ZY
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2050. PubMed ID: 38517478
[TBL] [Abstract] [Full Text] [Related]
11. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
12. The cell death-related genes machine learning model for precise therapy and clinical drug selection in hepatocellular carcinoma.
Du M; Qu Y; Qin L; Zheng J; Sun W
J Cell Mol Med; 2024 Apr; 28(7):e18168. PubMed ID: 38494848
[TBL] [Abstract] [Full Text] [Related]
13. Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate.
Arefnezhad R; Ashna S; Rezaei-Tazangi F; Arfazadeh SM; Seyedsalehie SS; Yeganeafrouz S; Aghaei M; Sanandaji M; Davoodi R; Abadi SRK; Vosough M
Cell Biol Int; 2024 May; 48(5):556-576. PubMed ID: 38411312
[TBL] [Abstract] [Full Text] [Related]
14. Interferon-α induces differentiation of cancer stem cells and immunosuppression in hepatocellular carcinoma by upregulating CXCL8 secretion.
Ma YT; Zheng L; Zhao CW; Zhang Y; Xu XW; Wang XY; Niu GP; Man ZS; Gu F; Chen YQ
Cytokine; 2024 May; 177():156555. PubMed ID: 38387232
[TBL] [Abstract] [Full Text] [Related]
15. USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the HK2/akt/P62 axis.
Zhang N; Zhang H; Yang X; Xue Q; Wang Q; Chang R; Zhu L; Chen Z; Liu X
BMC Cancer; 2024 Feb; 24(1):237. PubMed ID: 38383348
[TBL] [Abstract] [Full Text] [Related]
16. Exosomal miR-93 derived from hepatocellular carcinoma cell promotes the sorafenib resistance of hepatocellular carcinoma through PTEN/PI3K/akt pathway.
Bao Y; Xu S; Zhou J; Zhao C; Dai S; Zhang Y; Rao M
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23666. PubMed ID: 38375688
[TBL] [Abstract] [Full Text] [Related]
17. l-Methionine potentiates anticancer activity of Sorafenib by epigenetically altering DUSP3/ERK pathway in hepatocellular carcinoma.
Pal S; Kabeer SW; Sharma S; Tikoo K
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23663. PubMed ID: 38367245
[TBL] [Abstract] [Full Text] [Related]
18. NDC1 promotes hepatocellular carcinoma tumorigenesis by targeting BCAP31 to activate PI3K/akt signaling.
Liu YP; Guo G; Ren M; Li YR; Guo D; She JJ; He SX
J Biochem Mol Toxicol; 2024 Feb; 38(2):e23647. PubMed ID: 38348718
[TBL] [Abstract] [Full Text] [Related]
19. High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma.
Tao S; Cui D; Cheng H; Liu X; Jiang Z; Chen H; Gao Y
BMC Cancer; 2024 Feb; 24(1):194. PubMed ID: 38347489
[TBL] [Abstract] [Full Text] [Related]
20. Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients.
Wang S; Wu X; Wu X; Cheng J; Chen Q; Qi Z
BMC Cancer; 2024 Jan; 24(1):156. PubMed ID: 38291366
[TBL] [Abstract] [Full Text] [Related]
[Next]
